RYBELSUS

ਉਤਪਾਦ ਝਲਕ

About RYBELSUS

RYBELSUS is a medication that contains the active ingredient SEMAGLUTIDE, which is used to treat type 2 diabetes. It belongs to a class of medications known as glucagon-like peptide-1 (GLP-1) receptor agonists. RYBELSUS is designed to help improve blood sugar control and reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes.

Key Benefits & Uses

• Improves blood sugar control by increasing insulin secretion and decreasing glucagon secretion
• Reduces the risk of major adverse cardiovascular events, such as heart attacks, strokes, and deaths due to cardiovascular disease
• Can help with weight loss, as SEMAGLUTIDE can reduce appetite and increase feelings of fullness

Active Ingredient & Action

SEMAGLUTIDE, the active ingredient in RYBELSUS, works by mimicking the action of the natural hormone GLP-1 in the body. It binds to GLP-1 receptors in the pancreas, stimulating the release of insulin and decreasing the release of glucagon. This helps to lower blood sugar levels and improve insulin sensitivity.

Important Notes

It is essential to follow the prescribed dosage and administration instructions for RYBELSUS. Patients should also be aware of potential side effects, such as nausea, vomiting, and diarrhea. RYBELSUS is not recommended for patients with a history of pancreatitis or thyroid cancer. As with any medication, it is crucial to consult with a healthcare professional before starting treatment with RYBELSUS.